ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $402,924 | -23.6% | 134,308 | -4.8% | 0.00% | -100.0% |
| Q2 2023 | $527,545 | +127326.3% | 141,055 | +14.0% | 0.00% | 0.0% |
| Q1 2023 | $414 | -27.1% | 123,687 | +4.7% | 0.00% | 0.0% |
| Q4 2022 | $568 | -99.9% | 118,093 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $661,000 | -15.1% | 116,114 | +5.8% | 0.00% | 0.0% |
| Q2 2022 | $779,000 | +31.1% | 109,712 | +33.4% | 0.00% | 0.0% |
| Q1 2022 | $594,000 | -23.0% | 82,237 | -4.6% | 0.00% | 0.0% |
| Q4 2021 | $771,000 | -74.3% | 86,239 | +0.6% | 0.00% | -75.0% |
| Q3 2021 | $3,004,000 | +70.4% | 85,692 | +4.4% | 0.00% | +100.0% |
| Q2 2021 | $1,763,000 | +66.3% | 82,096 | +378.3% | 0.00% | +100.0% |
| Q1 2021 | $1,060,000 | +102.7% | 17,163 | +37.1% | 0.00% | 0.0% |
| Q4 2020 | $523,000 | – | 12,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |